Montreal, QC - Pioglitazone (Actos, Takeda) is associated with an increased risk of incident bladder cancer among those with type 2 diabetes, according to the results of a nested case-control study ...

Are you taking Pioglitazone? Are you aware of the dangers of combining Pioglitazone with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

NEW ORLEANS — Pioglitazone halved the progression to diabetes in people with insulin resistance and cerebrovascular disease, new data from the Insulin Resistance Intervention after Stroke (IRIS) trial ...

Please provide your email address to receive an email when new articles are posted on . Pioglitazone and SGLT2 inhibitors as add-ons to insulin therapy were more effective for lowing HbA1c, fasting ...

Indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM). Pioglitazone HCl is indicated for ...

Please provide your email address to receive an email when new articles are posted on . “We were disappointed that vitamin E did not work because the only other therapeutic approach that the liver ...

The results will not wipe out a recent $2.37 billion settlement reached in about 9000 bladder cancer claims involving the drug. A large-scale study published today in JAMA found that that use of ...

Findings of a meta-analysis show that pioglitazone use with a dose duration greater than 438 days was associated with a significantly reduced risk of Parkinson disease in patients with diabetes.

HONOLULU, HI—Patients with a prior stroke or TIA who have prediabetes detected using widely available clinical assessments seem to derive a benefit from pioglitazone, post hoc analysis of the IRIS ...

In a recent issue of JAMA, Lewis et al. present long-term data on the likelihood of a link between pioglitazone and the risk of bladder cancer and ten other cancers. Their findings contradict previous ...

Use of pioglitazone for 1 year or less, 1–2 years, and more than 2 years was associated with a 33%, 66%, and 78% increased risk of bladder cancer, respectively. A cumulative dose of 10,500 mg or less, ...